Penumbra, Inc.
$330.22
$2.79(-0.84%)
Penumbra, Inc.
PEN
$330.22
$2.79(-0.84%)
Penumbra, Inc.
PEN
NYSE
$330.22
$2.79(-0.84%)
Chart
Key stats
52-Week Range$330.22
$221.26
$362.41
Market capitalization
$12.95BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
73.22Basic EPS (TTM)
$4.57Net income (TTM)
$177.69MRevenue (TTM)
$1.40BAvg. volume
718.87KBeta (1Y)
0.84Employees
4.50KMarket capitalization
$12.95BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
73.22Basic EPS (TTM)
$4.57Net income (TTM)
$177.69MRevenue (TTM)
$1.40BAvg. volume
718.87KBeta (1Y)
0.84Employees
4.50KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Penumbra, Inc.
Sector
Healthcare
Industry
Medical - Devices
CEO
Adam Elsesser
Website
www.penumbrainc.comHeadquarters
One Penumbra Place, Alameda, CA, 94502
IPO Date
2015-09-18
Identifiers
ISIN
US70975L1070Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The...
Related Stocks
$189.61
1D:
-0.6%
1Y:
2.9%
US0162551016Healthcare
Mkt Cap
$13.58B
P/E Ratio TTM
34.1
Revenue TTM
$4.03B
Beta
1.81
Earnings TTM
$410.35M
Dividend Yield TTM
0.00%
$94.87
1D:
0.5%
1Y:
29.8%
US3795772082Healthcare
Mkt Cap
$12.83B
P/E Ratio TTM
23.7
Revenue TTM
$2.94B
Beta
1.09
Earnings TTM
$537.90M
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Actual
Estimate